Verification and optimization of the VTE risk stratification system for multiple myeloma

Journal of Thrombosis and Thrombolysis · Published 2026-06-10 · DOI 10.1007/s11239-026-03339-8

Authors (11)

Yuexiao Liu, Qian Li, Huixia Guo, Yue Wu, Yijuan Chen, Yang Liu, Xuelin Dou, Nan Peng, Xiaodong Mo, Jin Lu, Liru Wang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Liu, Y., Li, Q., Guo, H., et al. (2026). Verification and optimization of the VTE risk stratification system for multiple myeloma. Journal of Thrombosis and Thrombolysis. https://doi.org/10.1007/s11239-026-03339-8

Related articles

• The association of angiostatin and plasminogen plasma levels with Charlson comorbidity burden and mortality in COVID-19 · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Admission electrocardiographic markers of atrial cardiomyopathy predict persistent pulmonary hypertension and chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a retrospective cohort study · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Systemic immune-inflammation index predicts left atrial thrombus in non-valvular atrial fibrillation: A retrospective study of 847 patients · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• A qualitative study of warfarin self-management in the United States healthcare system: insights from patient experiences · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Opioid use disorder and clinical outcomes following percutaneous coronary intervention for acute coronary syndromes · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Localized antithrombotic but minimal systemic coagulation effects of sodium bicarbonate in mechanical circulatory support · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Long non-coding RNA NPPA-AS1 acts as a potential novel biomarker and promotes atrial fibrillation progression via the miR-302e/TGFBR2 axis · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Practice patterns of DOAC high-intensity period following parenteral lead-in treatment for venous thromboembolism · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Antiplatelet effects of oral anticoagulants in patients with atrial fibrillation: ex-vivo studies · Journal of Thrombosis and Thrombolysis · 2026 · Same journal
• Extended anticoagulation with DOACs in patients affected by hematologic malignancies and venous thromboembolism: a monocentric experience · Journal of Thrombosis and Thrombolysis · 2026 · Same journal